Name Altran Europe
Contact Christelle Roux (Business Manager)
Av. de Tervuren 142-144, Brussels, 1150, Belgium
  Tel: + 32 (0) 2 737 68 11
Email: reach@altran-europe.be
Web: www.altran-europe.be  
Work Areas
  • Consortium management
  • Dossier preparation & data management
  • IT & software services
  • Pre-registration/Registration
  • Risk assessment (environmental)
  • Risk assessment (human)
  • SIEF facilitation
  • Testing strategies
  • Training
  • Corporate strategy/advice
  • Supply chain communication
Company Background

Altran Europe is an innovation and technology consultancy, with 350 consultants in Belgium.

Altran Europe Solution Centre's (AE SC) main objective is to set up the appropriate organization in order to better answer our market evolutions through the creation and the development of added value solutions.

The AE SC is composed by 3 Business Lines:

  • Special Offers Business
    • Solutions Business Line: Development & System Integration, Restart (innovative answers to Energy issues), 3PM (solutions in project, program and portfolio management), Environment and Health (including REACH solutions, environment management and regulatory files).
      • Special Projects Business Line manages the company projects requiring a specific framework; resulting in a dedicated end-to-end approach.
      • The E&H Team of Solution Center provides strategic risk management and technical consulting services addressing a broad range of human health and environmental risk issues related to the presence of chemicals in the natural environment, the workplace and the consumer environment.

Offices Brussels (Belgium)
Work Area Details
Consortium management
Management of administrative tasks on consortia of one or several substances; bank account management, new member management; time management; meeting organization, archiving, ensuring complience with competition law; acting as independent party; management of the technical work: datagap analyses, writing study summaries, IUCLID5 dossier preparation, CSR
Dossier preparation & data management
Our team members are from different scientific fields and have knowledge on exposure assessment; experience with IUCLIDs; experiences in literature search and review, data interpretation, data gap filling.
IT & software services
More details can be provided on request at www.reach@altran-europe.be
Pre-registration/Registration
Assistance with compiling REACH; evaluate hazard classification and labelling; development of ES for downstream uses; preparation of CSR
Risk assessment (environmental)
Assistance with compiling REACH; evaluate hazard classification and labelling; development of ES for industry, associations and downstream uses; preparation of CSR
Risk assessment (human)
SIEF facilitation
Representing the SFF on the REACH, sameness discussions, SIEF discussions
Testing strategies
According to Article 23 of the REACH, testing on vertebrate animals for the purposes of the Regulation shall only be undertaken as a last option. The Commission supports efforts intended at reducing unnecessary animal testing. Information may be generated by other means, in particular by using non-animal tests (e.g. in vitro tests), estimation methods (e.g. QSARs) and by considering substance read-across data.
Training
Training on REACH, IUCLID 5
Corporate strategy/advice
Our team of consultants, with experience of working in industry and universities, research centres, can help you to identify understand how your business could be impacted by REACH
Supply chain communication
Clients chemical firms, energy sector, REACH substance consortia, petrochemicals, base chemicals, trainings and audits, downstream users, industry trade associations, biocide, SMEs and large businesses

Sign up to free news

Book your entry in the 2012 Service Providers Guide

Download media pack

Tel: +44 (0)1743 818 101
USA/Canada toll free: 1-866-861-9088
Email: june@chemicalwatch.com

-
-
-
-
-
-
-

Disclaimer: Information presented in this directory is based on submissions from companies themselves, and it should not be taken as any form of recommendation or approval on the part of CW Research Ltd.